

VP Watchlist
The VP Watchlist contains current coverage companies that deserve consideration for short term and long term portfolio additions.
Latest News

Indaptus Therapeutics (NASDAQ: INDP), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, has received approval from Health Canada to expand its clinica...
Read More
Serina Therapeutics (NYSE: SER, $4.91) has secured the second $5 million tranche of a $10 million equity financing deal, strengthening its financial position as it prepares to advance its lead Parkins...
Read More
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common ...
Read MoreVista Research

Blog & Newsletters
Exclusive daily market recaps & stories, weekly market views, and macroeconomic and investment newsletters help investors to stay current with real-time market coverage that is sent FREE directly to all that are in the Vista Network.
Learn More
Interviews
"Vista’s “Interviews Page” provides consolidated access to our sister organization Tribe Public’s Presentation and Q&A Event Webinar Series & other exciting interviews from other organizations that we would like to highlight from around the world."
Learn More